QLT, Inc. (USA) (QLTI)
$3.69
-0.03 (-0.81%)
| CAPS Rating |
|
|---|---|
| Open | $3.69 |
| Previous Close | $3.72 |
| Daily Range | $3.64 - $3.73 |
| 52-Week Range | $1.40 - $4.50 |
| Market Cap | $201.59M |
| P/E Ratio | 12.40 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 398,518 |
| Average Daily Volume | 484,000 |
QLTI
VS S&P 500 (SPY)
How do you think QLTI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
QLTI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
QLTI News and Commentary
- 3 Stocks Hitting High Notes – The Motley Fool
- 4-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- How to Avoid Bankruptcy – The Motley Fool
- 3 Stocks Ready to Roar – The Motley Fool
- 3 Stocks Ready to Roar – The Motley Fool
- 3 Stocks Attracting Top Investors – The Motley Fool
- Regeneron's Results Clearing Up – The Motley Fool
- A Big Upgrade for Allergan – The Motley Fool
- Barrier Taken Down – The Motley Fool
- Allergan's Unblemished Deal – The Motley Fool
- Hot Stocks You're Buying Now – The Motley Fool
- Hot Stocks You're Buying Now – The Motley Fool
- Wall Street's Buy List – The Motley Fool
- A Good Mix for QLT – The Motley Fool
- QLT's Blemished Aczone Clears Up – The Motley Fool
- Regeneron's Orphan Charms the FDA – The Motley Fool
- The Competition Bites Trimeris – The Motley Fool
- MGI's Turn for "Strategic Alternatives" – The Motley Fool
RSS Headlines
Fool UK
